Current progress and future trends in nanoparticle applications for lymphoma: a bibliometric analysis from 2004 to 2024

This bibliometric analysis suggests that several directions in NP applications for lymphoma may hold promise for near-term progress. NP-mediated chemotherapy and targeted therapy could improve drug delivery and help overcome resistance, while NP-based imaging agents may enhance sensitivity and enable real-time monitoring. The integration of NPs with CAR-T therapy may also offer strategies to improve efficacy and safety. Additional avenues, such as nanovaccines and green synthesis, highlight opportunities for immune modulation and biocompatibility. Despite notable translational challenges, multifunctional NP platforms may gradually contribute to advances in lymphoma management.